Renosen Pharmaceuticals Private Limited

Provides management consultancy services, incorporated in 2019, based in Gujarat.

2019 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Renosen Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 10.00 Cr
  • Satisfied Charges ₹ 3.00 Cr
  • Revenue Growth -49.52%
  • Profit Growth -65.99%
  • Ebitda -54.29%
  • Net Worth 21.10%
  • Total Assets 42.73%

About Renosen Pharmaceuticals

Renosen Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 2019 (Five years and 11 months 15 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Senores Lifesciences Private Limited. The Company is engaged in the Business Outsourcing Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Hemant Modi, Swapnil Shah, and Anar Shah serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51909GJ2019PTC108258

  • Company No.

    108258

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    22 May 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Business Outsourcing
Company report

Renosen Pharmaceuticals Private Limited

Explore comprehensive data for Renosen Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Renosen Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Hemant Modi Country flag representing In Director 01-Mar-2021Current
Swapnil Shah Country flag representing In Director 22-May-2019Current
Anar Shah Country flag representing In Director 22-May-2019Current

Financial Performance of Renosen Pharmaceuticals.

Renosen Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 49.52% decrease. The company also saw a substantial fall in profitability, with a 65.99% decrease in profit. The company's net worth Soared by an impressive increase of 21.1%.

Renosen Pharmaceuticals revenue growth over time
Renosen Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-49.52%
Revenue from Operations
-50.15%
Total Assets
42.73%
Profit or Loss
-65.99%
Net Worth
21.10%
EBITDA
-54.29%

What is the Ownership and Shareholding Structure of Renosen Pharmaceuticals?

Unlock access to Renosen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹100.00 M

Satisfied Charges

₹30.00 M

Charges Breakdown by Lending Institutions

  • Others : 10.00 Cr

Latest Charge Details

DateLenderAmountStatus
23 Jun 2021Others₹10.00 CrOpen
26 Mar 2021Others₹3.00 CrSatisfied

How Many Employees Work at Renosen Pharmaceuticals?

Unlock and access historical data on people associated with Renosen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Renosen Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Renosen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renosen Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Renosen Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Renosen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Renosen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.

  • Charges

    A charge with Others of Rs. 100.00 M registered on 23 Jun 2021 with Charge ID 100474691 was modified on 02 Jun 2022.

  • Charges

    A charge registered on 26 Mar 2021 via Charge ID 100459807 with Others was fully satisfied on 19 Aug 2021.

  • Charges

    A charge with Others amounted to Rs. 100.00 M with Charge ID 100474691 was registered on 23 Jun 2021.

  • Charges

    A charge with Others of Rs. 30.00 M registered on 26 Mar 2021 with Charge ID 100459807 was modified on 08 Jun 2021.

Frequently asked questions

  • What is the Incorporation or founding date of Renosen Pharmaceuticals Private Limited?

    Renosen Pharmaceuticals Private Limited was incorporated on 22 May 2019.

  • What is authorized share capital and paid-up capital of Renosen Pharmaceuticals Private Limited?

    The authorized share capital of Renosen Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Renosen Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Renosen Pharmaceuticals Private Limited.

    • Hemant Ishwarlal Modi
    • Swapnil Jatinbhai Shah
    • Anar Swapnil Shah

  • What is the registered address of Renosen Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Renosen Pharmaceuticals Private Limited is 1101 To 1103 South Tower One 42 B/H Ashok Vatika Nr.Jayantilal Park Brts, Ambli Bopal Roa D India, Ahmedabad, Gujarat, 380054.

  • What is the corporate identification number (CIN) and company number of Renosen Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Renosen Pharmaceuticals Private Limited is U51909GJ2019PTC108258 and the company number is 108258 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Renosen Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Renosen Pharmaceuticals Private Limited has fallen by -49.52%.

  • What change has been observed in the net worth of Renosen Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Renosen Pharmaceuticals Private Limited has experienced an upsurge of 21.10%.

  • What are the total open charges for Renosen Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Renosen Pharmaceuticals Private Limited amount to ₹ 10.00 Cr.

  • When was the last Balance Sheet of Renosen Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Renosen Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial